FDA Investigator Sony Mathews

Sony Mathews has inspections in 8 countries as of 27 Oct 2023. Sony Mathews has collaborated with a combinined 7298 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
200
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Brazil, China, Canada, United Kingdom of Great Britain and Northern Ireland, France
Co-Investigator(s):
Affiong Flores, Alan P Kurtzberg, Alice S Tsao, Alicia M Mozzachio, Althea A Williams, Amatul H Marium, Amber D Brodas, Amy Kim, Anastasia M Shields, Andrea A Branche, Andrew F Cohen, Andrew J Barrowcliff, Andrew M Abramowitz, Angela E Glenn, Anissa M Vargas, Anita Tiwari, Ankur C Patel, Ann L Demarco, Ann M Stewart, Anna M Alexander, Annet R Rajan, Anthony C Warchut, Anthony Kovalenko, Armia A Beshay, Arthur G Hurst, Ashley Defilippis, Azza Talaat, Bapu R Gaddam, Barbara J Rincon, Benton M Ketron, Betty M Ng Lee, Bijoy Panicker, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brian J Ryan, Bruce G Cooper, Candace S Tucker, Candace Y Gomez Broughton, Carl A Perez, Carla J Lundi, Carolyn J Cook, Carrie E Jolly, Cassandra L Abellard, Chad N Thomppson, Chagai L Winoker, Charanjeet Jassal, Charanjeet Jassal() (Cj), Charisse K Green, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Christine M Rivera, Christopher S Fields, Christopher S Keating, Coleburn E Vielehr, Constantin Y Philopoulos, Cynthia Jim, CSO, D Jeany Argiropoulos, D Jenny Argiropoulos, Daniel J Lahar, Daniel J Roberts, Daniel L Zheng, Daniel R Tammariello, David A Carlson, David D Anderson, PhD, David M Mcnew, David R Delucia, Deborah J Parris, Debra I Love, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Argiropoulos, Demitria J Xiradakis, Denise L Terzian, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Devon O Seymour, Diane E Bruce, Dilijeta Bajrami, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Dr. Carmelo Rosa, Dr. Erika A Pfeiler, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Duo D Chen, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Eric J Reisenauer, Eric M Silberhorn, Erica B Raphael, Erik W Koester, Erika E Englund, PhD, Erin L Nagel, Farhana Khan, Feiyan Jin, Felix Maldonado, Frank Verni, Frederick Razzaghi, Gajendiran Mahadevan, PhD, Gam S Zamil, Ganesh N Joshi, Gary J Lehr, Gary T Greco, Gayle S Lawson, Geoffrey K Wong, George C Amedro, Gladys B Casper, Gray, Gregson A Joseph, Gregson Joseph, Guerlain Ulysse, Gwyn G Dickinson, Harlan J Howard, Harry J Brewer, Hasan A Irier, PhD, Helen B Ricalde, Henry E Sanchez, Holly M Zahner, Hugh M Mcclure, II, Ilana Zigelman, Iram R Hassan, PhD, Ivis Lnegron Torres, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James D Bridges, James M Odonnell, Jane Chen, Janet A Rajan, Janete F Guardia, Jason D Tenney, Jawaid Hamid, Jay T Wong, Jazmine N Brown, Jeffery A Hangartner, Jennifer C Adams, Jennifer M Gogley, Jens Fricke, Jessica L Pressley, Jie He, Joanne M Schlossin, Jogy George, John A Podsadowski, John E Aghadia, John P Mistler, Johnna L Bleem, Jonathan G Matrisciano, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose O Hernandez, Jose Ohernandez Guzman, Jose R Hernandez, Jose Velez, Joseph J Vannelli, Joseph Maselli, Joseph Milcetic, Josh Renzon Ramilo, Joy P Matthias, Juan Rjimenez Garcia, Judy Keihl, Juklian M Badalucco, Juliana Falla, Juliana M Badalucco, Julie D Bringger, June P Page, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen L Kosar, Karishma G Gopaul, Karl Auguste, Katelyn Astaub Zamperini, Katherine E Jacobitz, Katherine L Huebner, Katherine Szestypalow, Kathryn A Nagy, Kazi Rafiquzzaman, Kejun Cheng, Kelli N Hicks, Kellia N Hicks, Kellie Leveille, Kenneth G Klobus, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Kimberley A Ricketts, Ko U Min, Krishna Ghosh, PhD, Kwong Lee, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, Lawrence W Farina, LCDR Chad N Thompson, LCDR Wilfred A Darang, Leena Thomas, Linda J Eason, Linda M Sacco, Lisa M Smith, LTJG Matthew R Palo, Luis A Dasta, Luis M Burgos Medero, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Marcia D Fields, Marcus A Ray, Margaret E Sarles, Margaret M Sands, Margaret N Klug, Maria Estrella, Maria Joselopez Barragan, PhD, Marie Bbuen Bigornia, Marie Elena C Puleo, Marijo B Kambere, PhD, Marisa R Eschmann, Marlene L Davis, Mary E Storch, Mary F Finn, Mary M Finn, Matthew A Sparato, Matthew A Spataro, Matthew B Casale, Matthew D Schnittker, Maxwell Van Tassell, PhD, Megan A Haggerty, Meredith P Soehl, Investigator, Michael A Charles, Michael A Taylor, Michael L Casner, Michael Levin, Michael Levine, Michael R Dominick, Michael R Goga, Michael S Chuley, Michael W Burd, Michele L Obert, Michelle Y Clark Stuart, Miguel A Martinez, Milan S Mcgorty, Milos Dokmanovic, PhD, Mindy M Chou, Minh D Phan, Morgan J Matthews, Mra Davism, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy M Espinal, Nariman Patenaude, Nazmul Hassan, Neal L Adams, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas C Mendiola, Nicholas J Morici, Nicole E Knowlton, Nicole Vaught, Nur M Faisal, Obinna R Echeozo, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul E Stein, Paul L Bellamy, Paul Mouris, Perez, Perry T Nichols, Peter Abel, Peter Caparelli, Peter E Baker, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Pratik S Upadhyay, DDC, Rachael A Moliver, Rachael O Oyewole, Rajiv R Srivastava, Raquel Gonzalez Rivera, Raymond Lam, Raymond Liu, Raymond M Lam, Rebecca E Cluster, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard K Glabach, Richard Ledwidge (nmi), PhD, Rita F Monfort, Robert C Steyert, Robert E Moncayo, Robert J Martin, Robert J Veitch, Robin P Mathew, Rochelle K Kimmel, Roger F Zabinski, Ronald Ifraimov, Rose Ljean Mary, Roseline N Boateng, Ruben C Quintana, Russ E Davis, S Lori Brown, PhD MPH, Samina S Khan, Samuel T Walker, Sandra D Thompson, Sangeeta M Khurana, PhD, Sarah A Meehan, Sarah A Wangseng, Sarah Kennett, PhD, Sasha M Latonis, Satheesh Thomas, Sayyem H Akbar, Seemay A Lee, Shantelle I Hughes, Shari L Kahn, Shirley J Berryman, Shreya Shah, Simone E Pitts, Sixto M Mercado Rios, Sonia E Ortiz, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacie A Woods, State Agency, Stella Yuen, Stephanie T Durso, Stephen J Mottola, Steven J Libal, Steven M Weinman, Sunita Vij, Susan M Jackson, Susan M Joseph, Susan W Ting, Susanna E Ford, Analyst, Syeda N Mahazabin, Tamil Arasu, PhD, Tammy Notto, Tammy S Notto, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Tej Poonai, Tekalign Wondimu, Teresa I Navas, Terry Bridgewater, Theressa B Smith, Thomas E Friel, Thomas J Mooney, Thomas P Hansen, Thuy T Nguyen, LCDR, Tomika L Bivens, Tonia F Bernard, Tonya R Johnson, Torrance J Slayton, Tracey L Harris, Tracy M Portelli, Tyanna N Hadley, Tzanko Stantchev, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Valerie A Potopsingh, Valerie L Whipp, Vanessa M Williams, Verlinda A Narcisse, Vivin George, Wayne E Seifert, Wayne J Meyer, Wayne S Fortenberry, Wendy G Tan, PhD, William A Warnick, William J Leonard, William M Rennells, William V Millar, Willie Wilson, Willy A Orantes, Xiaokuang Lai, PhD, Yasamin Ameri, Yumi J Hiramine, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Zachary A Bogorad, Zhaoyang Meng, Zhongren Wu, Zi Qiang Gu

Sony Mathews's Documents

Publish Date Document Type Title
October, 2012 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2012-10-16
June, 2018 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2018-06-29
August, 2014 FDA 483 POLYGEN PHARMACEUTICALS INC. - Form 483, 2014-08-29
June, 2015 FDA 483 Strides Pharma, Inc - Form 483, 2015-06-04
September, 2017 FDA 483 AARTI PHARMALABS LIMITED (custom synthesis Division) - Form 483, 2017-09-01
October, 2019 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2019-10-18
March, 2021 FDA 483 DR. REDDY'S LABORATORIES NEW YORK, INC. - Form 483, 2021-03-03
August, 2018 FDA 483 United-Guardian, Inc. - Form 483, 2018-08-02
September, 2018 FDA 483 Chartwell Pharmaceuticals Congers, LLC. - Form 483, 2018-09-26
April, 2014 EIR Radienz Living,LLC - EIR, 2014-04-09
April, 2017 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2017-04-13
April, 2016 EIR InvaGen Pharmaceuticals, Inc - EIR, 2016-04-30
February, 2022 FDA 483 Eywa Pharma Inc. - Form 483, 2022-02-02
October, 2019 EIR Regeneron Pharmaceuticals, Inc. - EIR, 2019-10-18
September, 2014 EIR P & L Development, LLC - EIR, 2014-09-17
January, 2012 FDA 483 Marksans Pharmaceuticals Ltd - Form 483, 2012-01-26
October, 2010 FDA 483 Professional Disposables International, Inc. - Form 483, 2010-10-21
September, 2010 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2010-09-16
November, 2018 EIR Port Jervis Laboratories, Inc - EIR, 2018-11-25
July, 2022 FDA 483 Brittonfield Laboratories - Form 483, 2022-07-08
December, 2009 FDA 483 Geritrex, LLC - Form 483, 2009-12-14
March, 2010 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2010-03-23
February, 2011 EIR Port Jervis Laboratories, Inc - EIR, 2011-02-28
September, 2022 FDA 483 Eurofarma Laboratorios S/A - Form 483, 2022-09-20
September, 2014 FDA 483 P & L Development, LLC - Form 483, 2014-09-17
April, 2017 EIR Sun Pharmaceutical Industries Limited - EIR, 2017-04-13
November, 2021 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2021-09-14
October, 2009 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2009-10-20
March, 2020 FDA 483 Ames Goldsmith Corp - Form 483, 2020-03-06
January, 2014 EIR Zydus Lifesciences Limited - EIR, 2014-01-31
December, 2017 FDA 483 Health Biotech Limited - Form 483, 2017-12-05
September, 2013 FDA 483 Ascent Pharmaceuticals Inc - Form 483, 2013-09-26
October, 2013 FDA 483 Cerovene, Inc. - Form 483, 2013-10-15
October, 2014 FDA 483 RX PHARMA-PACK, INC. - Form 483, 2014-10-10
January, 2019 FDA 483 Greenbrier International, Inc - Form 483, 2019-01-18
August, 2013 FDA 483 The Estee Lauder Inc - Form 483, 2013-08-05
November, 2014 FDA 483 Ultra Seal Corporation - Form 483, 2014-11-12
April, 2011 FDA 483 Professional Disposables International, Inc. - Form 483, 2011-04-20
January, 2020 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2020-01-31
December, 2018 FDA 483 Advance Pharmaceutical, Inc. - Form 483, 2018-12-13
January, 2014 FDA 483 Zydus Lifesciences Limited - Form 483, 2014-01-31
November, 2017 FDA 483 Vernon Packaging Inc - Form 483, 2017-11-08
November, 2009 EIR Auxilium Pharmaceuticals, LLC - EIR, 2009-11-24
January, 2019 FDA 483 Response Greenbrier International, Inc - Form 483R, 2019-02-05
February, 2010 FDA 483 Par Pharmaceuticals - Form 483, 2010-02-04
June, 2014 FDA 483 A&Z Pharmaceutical, Inc. - Form 483, 2014-06-03
May, 2016 FDA 483 Velocity Pharma LLC - Form 483, 2016-05-18
August, 2010 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2010-08-27
March, 2012 FDA 483 Taro Pharmaceuticals U.S.A., Inc. - Form 483, 2012-03-08
May, 2012 FDA 483 Lechler Laboratories Inc./ Mehron Inc. - Form 483, 2012-05-09
May, 2014 FDA 483 Allegiant Health - Form 483, 2014-05-07
March, 2022 FDA 483 CooperSurgical, Inc. - Form 483, 2022-03-04
August, 2015 FDA 483 Unimark Remedies Limited - Form 483, 2015-08-14
August, 2010 FDA 483 Ultra Seal Corporation - Form 483, 2010-08-03
October, 2014 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2014-10-24
March, 2021 FDA 483 Response DR. REDDY'S LABORATORIES NEW YORK, INC. - Form 483R, 2021-07-02
August, 2019 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2019-08-08
December, 2010 EIR Auxilium Pharmaceuticals, LLC - EIR, 2010-12-20
October, 2020 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2020-10-27
April, 2017 FDA 483 Contacare Ophthalmics & Diagnostics - Form 483, 2017-04-04
January, 2020 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2020-01-13
July, 2014 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2014-07-11
October, 2017 EIR CANTOR RESEARCH LABORATORIES INC - EIR, 2017-10-26
October, 2017 FDA 483 CANTOR RESEARCH LABORATORIES INC - Form 483, 2017-10-26
August, 2019 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2019-08-08
October, 2014 EIR Fresenius Kabi USA, LLC - EIR, 2014-10-24
March, 2022 FDA 483 Response CooperSurgical, Inc. - Form 483R, 2022-03-21
November, 2021 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2021-10-05
November, 2019 FDA 483 Essentials Biotech Co, Ltd. - Form 483, 2019-11-22
March, 2018 FDA 483 Bharat Explosives Limited - Form 483, 2018-03-09
June, 2019 FDA 483 Strides Pharma, Inc - Form 483, 2019-06-05
July, 2021 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2021-07-09
November, 2021 FDA 483 Ultra Seal Corporation - Form 483, 2021-11-19
October, 2020 FDA 483 Response Berkshire Sterile Manufacturing, Inc. - Form 483R, 2020-10-27
June, 2022 FDA 483 GC Hanford Manufacturing Company - Form 483, 2022-06-17
July, 2016 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2016-07-15
August, 2018 EIR United-Guardian, Inc. - EIR, 2018-08-02
April, 2019 FDA 483 The Skin Atelier, Inc. - Form 483, 2019-04-04
May, 2022 FDA 483 Aero Healthcare - Form 483, 2022-05-06
March, 2017 FDA 483 LNK International, Inc. - Form 483, 2017-03-07
September, 2018 EIR Chartwell Pharmaceuticals Congers, LLC. - EIR, 2018-09-26
April, 2019 FDA 483 Apothecus Pharmaceutical Corp. - Form 483, 2019-04-30
December, 2013 FDA 483 United-Guardian, Inc. - Form 483, 2013-12-16
May, 2018 EIR Innogenix, LLC. - EIR, 2018-06-07
February, 2011 FDA 483 Port Jervis Laboratories, Inc - Form 483, 2011-02-28
October, 2014 FDA 483 Spa Technologies International Inc - Form 483, 2014-10-03
April, 2022 EIR iuvo BioScience Operations, LLC - EIR, 2022-04-15
July, 2010 FDA 483 Elementis SRL, Inc. - Form 483, 2010-07-09
February, 2016 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2016-02-26
November, 2009 FDA 483 Price Master Corporation - Form 483, 2009-11-18
March, 2010 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2010-03-23
October, 2021 FDA 483 Greenbrier International, Inc - Form 483, 2021-10-05
October, 2018 FDA 483 Saptalis Pharmaceuticals LLC - Form 483, 2018-10-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more